With the objective to providing more efficient and user-friendly solutions for inhalation therapy, companies developing mesh nebulisers have adopted customisable platforms to fulfil an important unmet need in the market. As new therapies are developed, an increasing number of new biologic formulations in liquid form require the use of nebulisers.¹ This fact has gradually reignited the interest in these delivery systems. Among the nebuliser types, mesh nebulisers utilise a mesh plate to aerosolise liquid medication, offering an effective and portable solution for localised drug delivery, while reducing systemic adverse effects.

Formulations and nebulisers require an appropriate degree of tailoring to achieve higher delivery efficiency and adherence. Therefore, identifying the right formulation-nebuliser fit during early feasibility studies or at the pre-clinical stage greatly benefits the overall development; however, formulation-nebuliser combination implementations can be initiated at different stages of the development process. Nowadays, customisable mesh nebuliser platform developers can assist pharmaceutical companies in navigating several aspects of this journey through integrated services and solutions.